July 11, 2024

Hentons Corporate Finance is pleased to present a unique opportunity to acquire two companies that operate in the chemical manufacturing sector and the health and wellbeing industry.
The companies provide sustainable solutions to everyday health concerns, using the most natural ingredients e.g. allergies, sleeplessness and immunity.
The companies are award winning in their manufacturing and engineering along with their innovation within healthcare.
There are many opportunities to continue growth within these companies through ever evolving technology.
For more details, please click the button at the bottom of this email and view the Project Tulip Flyer.
To discuss details further with one of our team and for an NDA to be sent, please contact Jack or Matt as follows:
Jack Myers
jack.myers@hentons.com
07377 748723
Matt Milnes
matthew.milnes@hentons.com
07931 444 161
Autumn Budget 2026: Key Announcements
Webinar: Autumn Budget 2026 – What Could It Mean for You?
Payroll Webinar: Simplify Payroll & Payslip Queries
Hentons Corporate Finance Advises Armour Communications Shareholders on Acquisition by PentenAmio
Hentons Corporate Finance advises shareholders of JE Bennett Law on sale to Fletchers Group